Upstream Bio
(NASDAQ) UPB
Upstream Bio Financials at a Glance
Market Cap
$543.66M
Revenue (TTM)
$2.85M
Net Income (TTM)
$143.44M
EPS (TTM)
$-2.66
P/E Ratio
-3.75
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$9.92
Volume
6,613
Open
$9.91
Price
$9.92
Volume
6,613
Open
$9.91
Previous Close
$9.99
Daily Range
$9.78 - $9.98
52-Week Range
$7.25 - $33.68
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$9.92
Volume
6,613
Open
$9.91
Previous Close
$9.99
Daily Range
$9.78 - $9.98
52-Week Range
$7.25 - $33.68
UPB News
UPB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Upstream Bio
Industry
Biotechnology
Sector
Health CareEmployees
75
CEO
E. Rand Sutherland, MD
Website
www.upstreambio.comHeadquarters
Waltham, MA 02451, US
UPB Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-56%
Net Income Margin
-50%
Return on Equity
-35%
Return on Capital
-47%
Return on Assets
-41%
Earnings Yield
-26.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$543.66M
Shares Outstanding
54.42M
Volume
6.61K
Short Interest
0.00%
Avg. Volume
1.31M
Financials (TTM)
Gross Profit
$2.67M
Operating Income
$160.36M
EBITDA
$160.36M
Operating Cash Flow
$133.28M
Capital Expenditure
$165.00K
Free Cash Flow
$133.28M
Cash & ST Invst.
$341.51M
Total Debt
$1.27M
Upstream Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$668.00K
+9.0%
Gross Profit
$611.00K
-0.3%
Gross Margin
91.47%
N/A
Market Cap
$543.66M
N/A
Market Cap/Employee
$10.45M
N/A
Employees
52
N/A
Net Income
$42.46M
-99.9%
EBITDA
$46.11M
-75.5%
Quarterly Fundamentals
Net Cash
$340.24M
-27.4%
Accounts Receivable
$668.00K
-43.4%
Inventory
$0.00
N/A
Long Term Debt
$549.00K
-51.4%
Short Term Debt
$720.00K
+2.3%
Return on Assets
-40.55%
N/A
Return on Invested Capital
-47.12%
N/A
Free Cash Flow
$30.68M
-55.0%
Operating Cash Flow
$30.63M
-56.2%